Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article reviews the development of selective androgen receptor modulators and myostatin inhibitors as performance-enhancing drugs, highlighting ongoing challenges in achieving truly tissue-selective anabolic agents and reporting no new experimental findings.

In this study, researchers found that serum Myostatin levels and HOMA-IR were significantly higher in patients with androgenic alopecia compared to controls, suggesting they could be indicators of disease susceptibility and severity.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.